Ceres Research

CERES is a liquid biopsy research team at Massachusetts General Hospital.

The Ceres Research team focuses on bringing the power of liquid biopsy to the clinic for neurologic disorders. As one example, brain tumors reveal their presence in multiple ways. Liquid Biopsy is a tool to understand brain tumor signatures for the purpose of diagnosis and to gauge the efficacy of our therapies. CERES is led by a group of investigators focused on advancing clinical care by studying the nano-signatures of brain tumors as they are released into plasma and cerebrospinal fluid. Novel exosome, cell free nucleic acid, and protein based biomarkers are already beginning to change clinical practice.

Check back here for more updates on our work.